Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Amantadine Monotherapy Is Ineffective in the Treatment of Hepatitis C Virus Recurrence in the Post-Liver Transplantation Setting Muzi, F.
 2005
 37 4 p. 1705-1707
3 p.
 artikel
2 A Single-Dose of Cobalt-Protoporphyrin Protects Islet Beta Cells From Glucocorticoid Suppression Hsu, B.R.-S.
 2005
 37 4 p. 1826-1827
2 p.
 artikel
3 A “Steroid-Free” Tacrolimus and Low-Dose Mycophenolate Mofetil Primary Immunosuppression Does Not Prevent Early Acute Rejection After Liver Transplantation Reggiani, P.
 2005
 37 4 p. 1697-1699
3 p.
 artikel
4 Attenuation of Primary Nonfunction for Syngeneic Islet Graft Using Sodium 4-Phenylbutyrate Fu, S.-H.
 2005
 37 4 p. 1830-1831
2 p.
 artikel
5 Author Index 2005
 37 4 p. 1972-1974
3 p.
 artikel
6 Average P/F Ratio During Donor Management for Finding Out the Potential Donor of Lung Procurement Iwata, H.
 2005
 37 4 p. 1845-1847
3 p.
 artikel
7 Blockade of Fibronectin-α4β1 Adhesive Interactions Down-Regulates Cyclooxygenase-2 Inducible Nitric Oxide Synthase and Prolongs Recipient Survival in a 24-Hour Model of Cold Hepatic Ischemia-Reperfusion Injury Moore, C.
 2005
 37 4 p. 1682-1683
2 p.
 artikel
8 Calcineurin Inhibitors Block B-1 Cell Differentiation: The Relevance to Immunosuppressive Treatment in ABO-Incompatible Transplantation Zhou, W.
 2005
 37 4 p. 1808-1811
4 p.
 artikel
9 Cardiovascular Risk Estimates and Risk Factors in Renal Transplant Recipients Krämer, B.K.
 2005
 37 4 p. 1868-1870
3 p.
 artikel
10 Comparison of the Temporal Profile of Calcineurin Inhibition by Cyclosporine and Tacrolimus in Renal Transplant Patients Koefoed-Nielsen, P.B.
 2005
 37 4 p. 1736-1738
3 p.
 artikel
11 Comparison of the Vector Systems for Gene Transduction Into Rat Dendritic Cells and Peritoneal Exudate Cells Satoh, E.
 2005
 37 4 p. 1953-1956
4 p.
 artikel
12 Contents: 3rd International Congress on immunosuppression 2005
 37 4 p. xv-xxiii
nvt p.
 artikel
13 Conversion From Cyclosporine to Tacrolimus Results in Improved Creatinine But Does Not Alter Lipid Profile Woodside, K.J.
 2005
 37 4 p. 1877-1879
3 p.
 artikel
14 Conversion From Tacrolimus to Cyclosporin Is Associated With a Significant Improvement of Glucose Metabolism in Patients With New-Onset Diabetes Mellitus After Renal Transplantation Bouchta, N.B.
 2005
 37 4 p. 1857-1860
4 p.
 artikel
15 Cyclic RGD Peptides With High Affinity for α5β1 Integrin Protect Genetically Fat Zucker Rat Livers From Cold Ischemia/Reperfusion Injury Fondevila, C.
 2005
 37 4 p. 1679-1681
3 p.
 artikel
16 Cytokine Polymorphisms Do Not Influence Acute Rejection in Renal Transplantation Under Tacrolimus-Based Immunosuppression Loucaidou, M.
 2005
 37 4 p. 1760-1761
2 p.
 artikel
17 Determination of Cyclosporine and Its Metabolites in Blood via HPLC-MS and Correlation to Clinically Important Parameters Vollenbroeker, B.
 2005
 37 4 p. 1741-1744
4 p.
 artikel
18 Differential Effects of Cyclosporine and Tacrolimus on Mycophenolate Pharmacokinetics in Patients With Impaired Kidney Function Hohage, H.
 2005
 37 4 p. 1748-1750
3 p.
 artikel
19 Do Blood Pressure and Arterial Wall Properties Change After Conversion From Cyclosporine to Tacrolimus? Gelens, M.A.C.J.
 2005
 37 4 p. 1900-1901
2 p.
 artikel
20 Donor MHC Class I Peptides in Conjunction With Self-Epitopes Induce Donor-Specific Tolerance in a Dose-Dependent Manner But Unable to Abrogate Chronic Rejection Semiletova, N.V.
 2005
 37 4 p. 1937-1939
3 p.
 artikel
21 Down-Regulation of TGF-β and VCAM-1 Is Associated With Successful Treatment of Chronic Rejection in Rats Crews, G.M.
 2005
 37 4 p. 1926-1928
3 p.
 artikel
22 Editorial Board 2005
 37 4 p. vii-
1 p.
 artikel
23 Effects of Noninherited Maternal Antigens on Allotransplant Rejection in a Transgenic Mouse Model Akiyama, Y.
 2005
 37 4 p. 1940-1941
2 p.
 artikel
24 Effects of Rapamycin on the Arterial Inflammatory Response in Atherosclerotic Plaques in Apo-E Knockout Mice Naoum, J.J.
 2005
 37 4 p. 1880-1884
5 p.
 artikel
25 Effects of Tautomycetin on Proliferation and Fibronectin Secretion in Vascular Smooth Muscle Cells and Glomerular Mesangial Cells Kim, J.H.
 2005
 37 4 p. 1959-1961
3 p.
 artikel
26 Evaluation of Appropriate Blood Level in Continuous Intravenous Infusion From Trough Concentrations After Oral Administration Based on Area Under Trough Level in Tacrolimus and Cyclosporine Therapy Nakamura, Y.
 2005
 37 4 p. 1725-1727
3 p.
 artikel
27 Evaluation of Daclizumab to Reduce Delayed Graft Function in Non—Heart-Beating Renal Transplantation: A Prospective, Randomized Trial Wilson, C.
 2005
 37 4 p. 1774-1775
2 p.
 artikel
28 Experimental Isolation and Transplantation of Hepatocytes With the Use of Antibody Against Interleukin-2 Receptor (Daclizumab) as Immunosuppressive Agent Tsiolis, I.
 2005
 37 4 p. 1929-1930
2 p.
 artikel
29 Expression of Peroxisome Proliferator-Activated Receptor-γ in Renal Ischemia-Reperfusion Injury Matsuyama, M.
 2005
 37 4 p. 1684-1685
2 p.
 artikel
30 Factors Influencing the Onset of Diabetes Mellitus After Kidney Transplantation: A Single French Center Experience Marin, M.
 2005
 37 4 p. 1851-1856
6 p.
 artikel
31 Five-Year Follow-up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplantation González-Pinto, I.M.
 2005
 37 4 p. 1713-1715
3 p.
 artikel
32 FK506 Donor Pretreatment Improves Intestinal Graft Microcirculation and Morphology by Concurrent Inhibition of Early NF-κB Activation and Augmented HSP72 Synthesis Oltean, M.
 2005
 37 4 p. 1931-1933
3 p.
 artikel
33 Follow-up of Kidney Graft Recipients With Cyclosporine-Associated Hemolytic-Uremic Syndrome and Thrombotic Microangiopathy Bren, A.
 2005
 37 4 p. 1889-1891
3 p.
 artikel
34 Gonadal Function and Immunosuppressive Therapy After Renal Transplantation Tondolo, V.
 2005
 37 4 p. 1915-1917
3 p.
 artikel
35 HO-1 Upregulation Suppresses Type 1 IFN Pathway in Hepatic Ischemia/Reperfusion Injury Tsuchihashi, S.
 2005
 37 4 p. 1677-1678
2 p.
 artikel
36 Identification of Early Tolerance Regulator Genes Induced by Allochimeric Therapy Using Microarray-Based Genomewide Scan Liu, D.
 2005
 37 4 p. 1942-1943
2 p.
 artikel
37 IL-2 Antagonists: The European Perspective Platz, K.-P.
 2005
 37 4 p. 1783-1784
2 p.
 artikel
38 Immunosuppression After Pancreas Transplantation Gruessner, R.W.G.
 2005
 37 4 p. 1663-1666
4 p.
 artikel
39 Immunosuppression Withdrawal After Auxiliary Liver Transplantation for Acute Liver Failure Girlanda, R.
 2005
 37 4 p. 1720-1721
2 p.
 artikel
40 Immunosuppressive Effect of Long-Term Drainage of Thoracic Duct on Immunological Memory in Adult Thymectomized Rats Satoh, E.
 2005
 37 4 p. 1947-1948
2 p.
 artikel
41 Impact of CYP3A5 and MDR1(ABCB1) C3435T Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients Tada, H.
 2005
 37 4 p. 1730-1732
3 p.
 artikel
42 Impact of Steroid Withdrawal on Metabolic Parameters in a Series of 112 Enteric/Systemic-Drained Pancreatic Transplants Mark, W.
 2005
 37 4 p. 1821-1825
5 p.
 artikel
43 Improved Attainment of NKF Classified Lipid Target Levels After Conversion From Cyclosporine to Tacrolimus in Renal Graft Recipients Pohanka, E.
 2005
 37 4 p. 1874-1876
3 p.
 artikel
44 Improved Graft Survival in ABO-Incompatible Living Donor Kidney Transplantation Kaihara, S.
 2005
 37 4 p. 1804-1805
2 p.
 artikel
45 Improvement of Quality of Life in Tacrolimus-Based Pediatric Renal Transplant Recipients and Their Caregivers, Including Donors Hasegawa, A.
 2005
 37 4 p. 1771-1773
3 p.
 artikel
46 Incidence and Risk Factors of Clinical Characteristics, Tacrolimus Pharmacokinetics, and Related Genomic Polymorphisms for Posttransplant Diabetes Mellitus in the Early Stage of Renal Transplant Recipients Numakura, K.
 2005
 37 4 p. 1865-1867
3 p.
 artikel
47 Influence of Methicillin-Resistant Staphylococcus aureus Carrier Status in Liver Transplant Recipients Woeste, G.
 2005
 37 4 p. 1710-1712
3 p.
 artikel
48 Influence of Polyclonal ATGs on Expression of Adhesion Molecules: An Experimental Study Beiras-Fernandez, A.
 2005
 37 4 p. 1944-1946
3 p.
 artikel
49 Inhibition of MD-1 Expression by Immunosuppressants or Antisense Oligodeoxynucleotides on Skin Allograft Survival in Mice Zhang, X.
 2005
 37 4 p. 1965-1967
3 p.
 artikel
50 Initial Dosage Adjustment for Oral Administration of Tacrolimus Using the Intestinal MDR1 Level in Living-Donor Liver Transplant Recipients Masuda, S.
 2005
 37 4 p. 1728-1729
2 p.
 artikel
51 Introduction Busuttil, Ronald W.
 2005
 37 4 p. 1649-
1 p.
 artikel
52 Ischemia and Reperfusion Injury in Liver Transplantation Kupiec-Weglinski, J.W.
 2005
 37 4 p. 1653-1656
4 p.
 artikel
53 Kaposi Sarcoma in Solid Organ Transplant Recipients: A Single Center Report Boeckle, E.
 2005
 37 4 p. 1905-1909
5 p.
 artikel
54 Late Steroid Withdrawal for Renal Transplant Recipients on Tacrolimus and MMF Is Safe Loucaidou, M.
 2005
 37 4 p. 1795-1796
2 p.
 artikel
55 Lipid Metabolism in Renal Transplant Patients Receiving Tacrolimus/Sirolimus Combination Therapy Wlodarczyk, Z.
 2005
 37 4 p. 1871-1873
3 p.
 artikel
56 Liver-Induced Immune Tolerance in Recipients of Combined Liver-Intestine Transplants Goulet, O.
 2005
 37 4 p. 1689-1690
2 p.
 artikel
57 Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis: Prognostic Parameters Benckert, C.
 2005
 37 4 p. 1693-1694
2 p.
 artikel
58 Liver Transplantation for Primary Biliary Cirrhosis: Influence of Primary Immunosuppression on Survival Jacob, D.A.
 2005
 37 4 p. 1691-1692
2 p.
 artikel
59 Long-Term Challenges of Immunosuppression in Pediatric Patients Kelly, D.A.
 2005
 37 4 p. 1657-1662
6 p.
 artikel
60 Long-Term Immunosuppression for Prevention of Nonviral Disease Recurrence Neuberger, J.
 2005
 37 4 p. 1671-1674
4 p.
 artikel
61 Long-Term Outcome of Immunosuppression Withdrawal After Liver Transplantation Girlanda, R.
 2005
 37 4 p. 1708-1709
2 p.
 artikel
62 Long-Term Results of Tacrolimus Therapy for Renal Transplantation in Patients With Diabetic Nephropathy in Japan Sugitani, A.
 2005
 37 4 p. 1767-1768
2 p.
 artikel
63 Magnesium Supplementation Prevents Chronic Cyclosporine Nephrotoxicity via Adjusting Nitric Oxide Synthase Activity Yuan, J.
 2005
 37 4 p. 1892-1895
4 p.
 artikel
64 Neoquadruple Induction With Antithymocyte Globulin/Azathioprine/Cyclosporine/Prednisolone in Simultaneous Pancreas and Kidney Transplant Recipients: 8.5-Year Results Schulz, T.
 2005
 37 4 p. 1815-1817
3 p.
 artikel
65 New Protocol of Immunosuppression for Liver Transplantation Across ABO Barrier: The Use of Rituximab, Hepatic Arterial Infusion, and Preservation of Spleen Yoshizawa, A.
 2005
 37 4 p. 1718-1719
2 p.
 artikel
66 No Increase in Rejection or Graft Loss in Kidney Transplant Recipients With Thrombophilia Treated With Anticoagulation and Triple Immunosuppression Pagano, C.R.
 2005
 37 4 p. 1902-1904
3 p.
 artikel
67 No Influence of Immunosuppression on Insulin Sensitivity and β-Cell Function in Living Donor Liver Transplantation Stockmann, M.
 2005
 37 4 p. 1861-1864
4 p.
 artikel
68 Optimal Dose and Target Trough Level in Cyclosporine and Tacrolimus Conversion in Renal Transplantation as Evaluated by Lymphocyte Drug Sensitivity and Pharmacokinetic Parameters Takeuchi, H.
 2005
 37 4 p. 1745-1747
3 p.
 artikel
69 Pharmacokinetic Differences Between Morning and Evening Administration of Cyclosporine and Tacrolimus Therapy Iwahori, T.
 2005
 37 4 p. 1739-1740
2 p.
 artikel
70 Preservation of Renal Function After Heart Transplantation: Initial Single-Center Experience With Sirolimus De Meester, J.M.J.
 2005
 37 4 p. 1835-1838
4 p.
 artikel
71 Prognosis of HTLV-I-Positive Renal Transplant Recipients Nakamura, N.
 2005
 37 4 p. 1779-1782
4 p.
 artikel
72 Protective Effects of PG490-88 on Chronic Allograft Rejection by Changing Intragraft Gene Expression Profiles Fisniku, O.
 2005
 37 4 p. 1962-1964
3 p.
 artikel
73 Regimen of Tacrolimus-Based Immunosuppression With Basiliximab, Mycophenolate Mofetil, and Low-Dose Steroid Reduces Acute Rejection in Kidney Transplants Hoshinaga, K.
 2005
 37 4 p. 1762-1763
2 p.
 artikel
74 Relationship Between Immunosuppression and Osteoporosis in an Outpatient Liver Transplant Clinic Smallwood, G.A.
 2005
 37 4 p. 1910-1911
2 p.
 artikel
75 Repeated Steroid Pulse Therapies in HCV-Positive Liver Recipients: Significant Risk Factor for HCV-Related Graft Loss Bahra, M.
 2005
 37 4 p. 1700-1702
3 p.
 artikel
76 Results of the Paris Program: Ten Years of Pediatric Intestinal Transplantation Goulet, O.
 2005
 37 4 p. 1667-1670
4 p.
 artikel
77 Retrospective Analysis of the Impact of Immunosuppression on the Course of Recurrent Hepatitis C After Liver Transplantation Bahr, M.J.
 2005
 37 4 p. 1703-1704
2 p.
 artikel
78 Rheological Properties of Red Blood Cells in Kidney Transplant Recipients: The Role of Lipid Profile and Type of Immunosuppresion Chmiel, B.
 2005
 37 4 p. 1885-1888
4 p.
 artikel
79 Role of Dietary Salt Intake in Posttransplant Hypertension With Tacrolimus-Based Immunosuppression Prasad, G.V.R.
 2005
 37 4 p. 1896-1897
2 p.
 artikel
80 Safety Analysis After Tacrolimus Immunosuppression in Renal Transplant Recipients in Japan: 5-Year Results in >1500 Patients Yoshimura, N.
 2005
 37 4 p. 1764-1766
3 p.
 artikel
81 sCD30 and Neopterin as Risk Factors of Chronic Renal Transplant Rejection: Impact of Cyclosporine A, Tacrolimus, and Mycophenolate Mofetil Weimer, R.
 2005
 37 4 p. 1776-1778
3 p.
 artikel
82 Severe Hearing Loss After Liver Transplantation Rifai, K.
 2005
 37 4 p. 1918-1919
2 p.
 artikel
83 Single-Shot Antithymocyte Globuline and Daclizumab Induction in Simultaneous Pancreas and Kidney Transplant Recipient: Three-Year Results Schulz, T.
 2005
 37 4 p. 1818-1820
3 p.
 artikel
84 Splenic Radiation and Double-Filtration Plasmapheresis in Crossmatch-Positive Live Renal Transplantation Ravichandran, P.
 2005
 37 4 p. 1806-1807
2 p.
 artikel
85 Steroid Avoidance Immunosuppression in Low-Risk Kidney Transplant Recipients Heilman, R.L.
 2005
 37 4 p. 1785-1788
4 p.
 artikel
86 Steroid Sparing in Renal Transplantation With Tacrolimus and Mycophenolate Mofetil: Three-Year Results Borrows, R.
 2005
 37 4 p. 1792-1794
3 p.
 artikel
87 Steroid Withdrawal or Steroid Avoidance in Renal Transplant Recipients: Focus on Tacrolimus-Based Immunosuppressive Regimens Krämer, B.K.
 2005
 37 4 p. 1789-1791
3 p.
 artikel
88 Successful Conversion to Rapamycin for Calcineurin Inhibitor-Related Neurotoxicity Following Liver Transplantation Forgacs, B.
 2005
 37 4 p. 1912-1914
3 p.
 artikel
89 Successful Management of Recurrent Epstein-Barr Virus-Associated Multilocular Leiomyosarcoma After Cardiac Transplantation Bonatti, H.
 2005
 37 4 p. 1839-1844
6 p.
 artikel
90 Successful Results After 5 Years of Tacrolimus Therapy in ABO-Incompatible Kidney Transplantation in Japan Takahashi, K.
 2005
 37 4 p. 1800-1803
4 p.
 artikel
91 Successful Treatment of 115 Pediatric Renal Transplant Recipients With Tacrolimus-Based Immunosuppressive Therapy: A 7-Year Multicenter Study in Japan Hasegawa, A.
 2005
 37 4 p. 1769-1770
2 p.
 artikel
92 Survival Prolongation of Microencapsulated Allogeneic Islet by Nanosized Nordihydroguaiaretic Acid Yang, T.-Y.
 2005
 37 4 p. 1828-1829
2 p.
 artikel
93 Switching Immunosuppression From Cyclosporine to Tacrolimus Improves Long-Term Kidney Function: A 6-Year Study Hohage, H.
 2005
 37 4 p. 1898-1899
2 p.
 artikel
94 Tacrolimus Monitoring in Renal Transplantation: A Comparison Between High-Performance Liquid Chromatography and Immunoassay Borrows, R.
 2005
 37 4 p. 1733-1735
3 p.
 artikel
95 The Cost of Steroid-Free Protocols in Primary Cadaver Kidney Transplantation Nghiem, D.D.
 2005
 37 4 p. 1797-1799
3 p.
 artikel
96 The Influence of Late Acute Rejection Episodes on Long-Term Graft Outcome After Liver Transplantation Junge, G.
 2005
 37 4 p. 1716-1717
2 p.
 artikel
97 The Influence of Mycophenolate Mofetil Versus Azathioprine and Mycophenolic Acid Pharmacokinetics on the Incidence of Acute Rejection and Infectious Complications After Renal Transplantation Satoh, S.
 2005
 37 4 p. 1751-1753
3 p.
 artikel
98 The Malononitrilamide FK778 Inhibits Activation of NF-κB in Human Dendritic Cells Zeyda, M.
 2005
 37 4 p. 1968-1969
2 p.
 artikel
99 The Novel Immunosuppressant FK778 Inhibits Formation of the Immunologic Synapse Zeyda, M.
 2005
 37 4 p. 1970-1971
2 p.
 artikel
100 The Pathologic Impact of Tacrolimus on Protocol Biopsy in Renal Transplant Patients With Basiliximab-Based Immunosuppression Sakai, K.
 2005
 37 4 p. 1757-1759
3 p.
 artikel
101 T-lymphocyte Apoptosis Is Increased by Non-Interleukin-2-Dependent Induction in Human Mixed Lymphocyte Cultures Woodside, K.J.
 2005
 37 4 p. 1949-1952
4 p.
 artikel
102 Use of Echocardiography to Assess Function of hDAF-Transgenic Pig Cardiac Xenografts Chan, M.C.Y.
 2005
 37 4 p. 1923-1925
3 p.
 artikel
103 Various Costimulatory Pathways Are Essential for Induction of Regulatory Cells by Intratracheal Delivery of Alloantigen Aramaki, O.
 2005
 37 4 p. 1934-1936
3 p.
 artikel
104 Withdrawal of Steroids: A Randomized Prospective Study of Prednisone and Tacrolimus Versus Mycophenolate Mofetil and Tacrolimus in Liver Transplant Recipients With Autoimmune Hepatitis Junge, G.
 2005
 37 4 p. 1695-1696
2 p.
 artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland